Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/28da8f7d-c009-4062-bcb4-11f9066859e7/

LMRI

Lumexa Imaging Holdings, Inc. Common Stock
Chart
$8.50
Latest Week 2026-06-05
HealthcareMedical DevicesSMALL
Snapshot 2026-06-07 · 0.0w · Fresh
0.47
OS Score
47.0%
Value
46.0%
Quality
47.0%
Momentum
8/9
F-Score
0.465
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
47.0%ile
P/S
0.8×
P/B
1.4×
FCF Yield
0.025
EBITDA/EV
0.051
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
53.00000000
/100 — 1=cheapest
VC2 (Trending Value)
53.00000000
/100
VC3 (Buyback)
53.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
46.0%ile
ROE
-0.079
ROA
-0.027
Net Margin
-0.046
Op Margin
0.026
GPA
0.066
D/E
1.94
Current
1.40
F-Score
8/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.078
Accruals
-0.036
lower=better
5yr Consist
No
F-Score of 8/9 indicates strong fundamental improvement across multiple dimensions.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
47.0%ile
Vol 252d
104.2%
Vol 60d
117.9%
↑ Expanding
Max DD 12M
-60.9%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.47
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
20.4%
Sector Quality %ile
19.4%
P/B z-score
-0.30
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
50.7% avg (5 factors)
Quality
F
24.8% avg (8 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.470—0—
Value %ile0.470—0—
Quality %ile0.460—0—
Momentum %ile0.470—0—
F-Score8.000—1—
Confidence0.758—1—
Volatility1.042—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
0.80
Price / Book
1.36
Price / Cash Flow
47.78
FCF Yield
2.5%
EBITDA / EV
5.1%
Sales Yield (1/P·S)
0.6307
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-7.9%
Return on Assets
-2.7%
Net Margin
-4.6%
Operating Margin
2.6%
Gross Profit / Assets
Novy-Marx GPA
6.6%
Debt / Equity
1.94
Current Ratio
1.40
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.036
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
7.8%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
8
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
53
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
53
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
53
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity